Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Nuclear Medicine: Page 31
Ga-68 PSMA-11 improves outcomes in prostate cancer patients
By
Will Morton
PET with a gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA)-11 radiotracer should be the standard imaging modality for guiding stereotactic ablative radiotherapy in oligometastatic prostate cancer patients, according to a June 29 study in
Clinical and Translational Radiation Oncology
.
July 1, 2021
AuntMinnie.com Molecular Imaging Insider
By
Will Morton
June 29, 2021
Tau PET bests amyloid PET, MRI in Alzheimer's prognostic study
By
Will Morton
Tau PET is superior to amyloid PET and MRI for detecting cognitive decline in Alzheimer's disease patients over time and may serve as a prognostic tool to help manage patients in the early stages of the disease, according to a study published June 28 in
JAMA Neurology
.
June 28, 2021
RayzeBio, Nimble ink research collaboration
By
AuntMinnie.com staff writers
RayzeBio and Nimble Therapeutics plan to collaborate on the discovery and development of novel peptide-based radiopharmaceuticals for cancer treatment.
June 27, 2021
Telix, Monrol reach agreement on therapeutic isotope supply
By
AuntMinnie.com staff writers
Telix Pharmaceuticals has signed a global clinical supply agreement with Istanbul-based Eczacıbaşı-Monrol Nuclear Products (Monrol) for the supply of no-carrier-added lutetium-177, a therapeutic isotope used in Telix's portfolio of molecularly targeted radiation products.
June 27, 2021
Researchers report on PET/CT's COVID-19 pandemic performance
By
Will Morton
When it comes to imaging diseases like COVID-19, FDG-PET/CT may not be the first modality that springs to mind. But its performance over the past year for identifying infection and inflammation in COVID-19 patients offers strong evidence of its value.
June 27, 2021
Humana expands nuclear medicine coverage
By
AuntMinnie.com staff writers
Humana will now cover PET/CT for cardiac/neurologic indications and SPECT/CT for others, according to the Society of Nuclear Medicine and Molecular Imaging.
June 21, 2021
Patient vest monitors dose after radionuclide therapy
By
Will Morton
Researchers are developing a radiation tracking vest for patients to wear at home to monitor radiation dose to organs during radionuclide therapy, according to a study presented at the 2021 annual meeting of the Society of Nuclear Medicine and Molecular Imaging.
June 17, 2021
Molecular imaging saw wins, losses over past year
By
Will Morton
You win some, you lose some. That adage could apply to the efforts of the nuclear medicine and molecular imaging community over the past year, according to the president's address by Alan Packard, PhD, at this week's annual Society of Nuclear Medicine and Molecular Imaging meeting.
June 16, 2021
Healthcare disparities persist as COVID-19 pandemic fades
By
Amerigo Allegretto
Dr. Sampson Davis, an emergency medicine physician and
New York Times
bestselling author, spoke at the SNMMI 2021 virtual annual meeting about his life growing up, attending medical school, and being on the frontlines of the COVID-19 pandemic. He also called others to action in the fight against racial injustice.
June 15, 2021
SNMMI's Image of the Year shows COVID-19's long-term neuro effects
By
Will Morton
A series of FDG-PET images of COVID-19 patients that shows how the disease causes long-term neurological changes associated with cognitive impairment was given Image of the Year honors at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting.
June 14, 2021
SNMMI releases slate of officers for 2021-2022 term
By
AuntMinnie.com staff writers
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released its slate of officers for its 2021-2022 term, headed by Dr. Richard Wahl as president.
June 14, 2021
Previous Page
Page 31 of 438
Next Page
